PT1831237E - Pró-fármaco amida da gemcitabina, suas composições e utilizações - Google Patents

Pró-fármaco amida da gemcitabina, suas composições e utilizações Download PDF

Info

Publication number
PT1831237E
PT1831237E PT05852411T PT05852411T PT1831237E PT 1831237 E PT1831237 E PT 1831237E PT 05852411 T PT05852411 T PT 05852411T PT 05852411 T PT05852411 T PT 05852411T PT 1831237 E PT1831237 E PT 1831237E
Authority
PT
Portugal
Prior art keywords
gemcitabine
compositions
amide prodrug
prodrug
amide
Prior art date
Application number
PT05852411T
Other languages
English (en)
Inventor
David Michael Bender
David Michael Remick
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT1831237E publication Critical patent/PT1831237E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/073Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
PT05852411T 2004-12-17 2005-11-30 Pró-fármaco amida da gemcitabina, suas composições e utilizações PT1831237E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63742204P 2004-12-17 2004-12-17

Publications (1)

Publication Number Publication Date
PT1831237E true PT1831237E (pt) 2008-09-22

Family

ID=36168678

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05852411T PT1831237E (pt) 2004-12-17 2005-11-30 Pró-fármaco amida da gemcitabina, suas composições e utilizações

Country Status (31)

Country Link
US (1) US7691827B2 (pt)
EP (1) EP1831237B1 (pt)
JP (1) JP5022911B2 (pt)
KR (1) KR100874052B1 (pt)
CN (1) CN101080417B (pt)
AR (1) AR055009A1 (pt)
AT (1) ATE405573T1 (pt)
AU (1) AU2005316922B2 (pt)
BR (1) BRPI0519117A2 (pt)
CA (1) CA2589850C (pt)
CY (1) CY1108447T1 (pt)
DE (1) DE602005009255D1 (pt)
DK (1) DK1831237T3 (pt)
EA (1) EA011868B1 (pt)
ES (1) ES2310860T3 (pt)
HR (1) HRP20080529T3 (pt)
IL (1) IL183666A (pt)
MA (1) MA29154B1 (pt)
MX (1) MX2007007228A (pt)
MY (1) MY143677A (pt)
NO (1) NO20073368L (pt)
NZ (1) NZ554732A (pt)
PE (1) PE20060771A1 (pt)
PL (1) PL1831237T3 (pt)
PT (1) PT1831237E (pt)
RS (1) RS50629B (pt)
SI (1) SI1831237T1 (pt)
TW (1) TWI326687B (pt)
UA (1) UA86119C2 (pt)
WO (1) WO2006065525A1 (pt)
ZA (1) ZA200705019B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2043653B1 (en) * 2006-06-21 2013-12-25 Eli Lilly And Company Crystalline forms of gemcitabine amide prodrug, compositions and use thereof
TWI436775B (zh) 2007-08-24 2014-05-11 Oncotherapy Science Inc 以抗原胜肽合併化療藥劑治療胰臟癌
CN101525361B (zh) 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
WO2014074725A1 (en) 2012-11-07 2014-05-15 Ohio State Innovation Foundation Substituted gemcitabine aryl amide analogs
WO2014078295A1 (en) 2012-11-13 2014-05-22 BoYen Therapeutics, Inc. Gemcitabine prodrugs and uses thereof
WO2015134334A1 (en) 2014-03-03 2015-09-11 Suo Zucai Gemcitabine analogs
WO2016078160A1 (zh) * 2014-11-17 2016-05-26 常州方圆制药有限公司 胞苷衍生物及其应用
US10435429B2 (en) 2017-10-03 2019-10-08 Nucorion Pharmaceuticals, Inc. 5-fluorouridine monophosphate cyclic triester compounds
EP3752511A4 (en) 2018-01-10 2021-12-29 Nucorion Pharmaceuticals, Inc. Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
CA3091027A1 (en) 2018-02-02 2019-08-08 Maverix Oncology, Inc. Small molecule drug conjugates of gemcitabine monophosphate
AU2019258590B2 (en) * 2018-04-26 2022-09-08 NanoMed Holdings Pty Ltd Gemcitabine amphiphile prodrugs
CN108864250A (zh) * 2018-05-29 2018-11-23 北京大学 一种FAPα酶敏感的吉西他滨前体药物及其制备方法和应用
SG11202100411TA (en) * 2018-08-03 2021-02-25 Cellix Bio Private Ltd Compositions and methods for the treatment of cancer
EP3999519A4 (en) 2019-07-17 2023-08-16 Nucorion Pharmaceuticals, Inc. CYCLIC DEOXYRIBONUCLEOTIDE COMPOUNDS
WO2021216427A1 (en) 2020-04-21 2021-10-28 Ligand Pharmaceuticals, Inc. Nucleotide prodrug compounds
PL442924A1 (pl) * 2022-11-23 2024-05-27 Politechnika Śląska Prolek - glikokoniugat pochodny gemcytabiny, jako związek o działaniu przeciwnowotworowym, sposób otrzymywania i zastosowanie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
RU2131880C1 (ru) * 1992-06-22 1999-06-20 Эли Лилли Энд Компани Способ получения обогащенных бета-аномером нуклеозидов
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
WO1998032762A1 (en) * 1997-01-24 1998-07-30 Norsk Hydro Asa Gemcitabine derivatives
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6624142B2 (en) * 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US6376470B1 (en) * 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
EP1567169A4 (en) * 2002-11-04 2009-10-21 Xenoport Inc GEMCITABINE PROMOTERS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
US7846436B2 (en) * 2003-11-28 2010-12-07 Chemgenes Corporation Oligonucleotides and related compounds

Also Published As

Publication number Publication date
CY1108447T1 (el) 2014-04-09
CN101080417A (zh) 2007-11-28
BRPI0519117A2 (pt) 2008-12-23
MA29154B1 (fr) 2008-01-02
AR055009A1 (es) 2007-08-01
RS50629B (sr) 2010-06-30
CA2589850C (en) 2012-05-01
HK1109903A1 (en) 2008-06-27
TW200634023A (en) 2006-10-01
AU2005316922B2 (en) 2011-08-25
JP2008524218A (ja) 2008-07-10
WO2006065525A1 (en) 2006-06-22
AU2005316922A1 (en) 2006-06-22
ZA200705019B (en) 2008-10-29
PL1831237T3 (pl) 2009-01-30
DK1831237T3 (da) 2008-10-27
KR100874052B1 (ko) 2008-12-12
IL183666A (en) 2011-09-27
PE20060771A1 (es) 2006-09-23
TWI326687B (en) 2010-07-01
IL183666A0 (en) 2007-09-20
MY143677A (en) 2011-06-30
MX2007007228A (es) 2007-08-14
ES2310860T3 (es) 2009-01-16
UA86119C2 (ru) 2009-03-25
ATE405573T1 (de) 2008-09-15
SI1831237T1 (sl) 2009-02-28
CN101080417B (zh) 2011-01-19
DE602005009255D1 (de) 2008-10-02
KR20070086308A (ko) 2007-08-27
US20090156547A1 (en) 2009-06-18
HRP20080529T3 (en) 2008-12-31
US7691827B2 (en) 2010-04-06
EP1831237A1 (en) 2007-09-12
NZ554732A (en) 2010-09-30
EP1831237B1 (en) 2008-08-20
JP5022911B2 (ja) 2012-09-12
NO20073368L (no) 2007-07-16
CA2589850A1 (en) 2006-06-22
EA200701300A1 (ru) 2007-10-26
EA011868B1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
ZA200705019B (en) Amide prodrug of gemcitabine, compositions and use thereof
IL204977A0 (en) Amide inhibitors of voltage-gated sodium channels, compositions comprising the same and uses thereof
IL191937A0 (en) Levodopa prodrug mesylate, compositions thereof and uses thereof
PL1751087T3 (pl) Pochodne lewodopy oraz ich kompozycje i zastosowania
IL189011A0 (en) COMPOSITIONS OF tRNA AND USES THEREOF
PL2335782T3 (pl) Zastosowanie kompozycji zawierającej HFCO-1233zd
IL190506A0 (en) Amide derivatives and pesticidal compositions containing the same
SI2057153T1 (sl) (3-ril-piperazin-1-il) derivati 6,7-dialkoksikuinazolin, 6,7-dialkoksiftalazin in 6,7-dialkoksiizokuinolin
ZA200704295B (en) Arthrospira-based compositions and uses thereof
ZA200700809B (en) Corrosion-inhibiting compositions and use thereof
IL182126A (en) Preparations containing and used in the history of 5-phenoxyalkoxypsoralen
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
EP1954685A4 (en) FUROXANE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
LT1858481T (lt) Oftalmologinės kompozicijos ir jų panaudojimas
IL186337A0 (en) Stannsoporfin compositions and administration
GB0622399D0 (en) Novel compositions and uses thereof
IL186606A0 (en) Compositions and uses of amooranin compounds
EP2076281A4 (en) STABILIZING ALKYLGLYCOSIDIC COMPOSITIONS AND METHODS THEREOF
ZA200707529B (en) Pro-fragrance and pro-flavorant compositions
ZA200804681B (en) Inhibitors of C-Met and uses thereof
GB0424051D0 (en) Compounds and compositions
GB2423081B (en) Pro-fragrance and pro-flavorant compositions
EP2010141A4 (en) NUCLEOTIDE COMPOSITIONS HAVING HIGH DEPOSITS AND USES THEREOF
GB0501348D0 (en) Compositions and methods
GB0622400D0 (en) Novel compositions and uses thereof